News · 26 weeks49+200%
2026-04-192026-10-11
Mix2390d
- SEC Filings9(39%)
- Other5(22%)
- Earnings4(17%)
- Analyst2(9%)
- Insider2(9%)
- Leadership1(4%)
Latest news
25 items- SECSEC Form 8-K filed by Accendra Health Inc.8-K - ACCENDRA HEALTH INC/VA/ (0000075252) (Filer)
- PRAccendra Health Receives Continued Listing Standard Notice from NYSE; Intends to Cure Deficiency and Return to Compliance with NYSE Listing StandardAccendra Health, Inc. (NYSE:ACH) (the Company) today announced that on October 6, 2026, it received a notice (the "Notice") from the New York Stock Exchange (the "NYSE") notifying the Company that it is not in compliance with the NYSE’s continued listing standards because the average closing price of the Company’s Class A Common Stock (the "Common Stock") was less than $1.00 per share over a consecutive 30 trading-day period. The Notice does not result in the immediate delisting of the Company’s Common Stock from the NYSE. The Company intends to respond to the NYSE within ten business days of receipt of the Notice affirming its intent to cure the deficiency. Pursuant to the NYSE’s rul
- SECSEC Form SCHEDULE 13G filed by Accendra Health Inc.SCHEDULE 13G - ACCENDRA HEALTH INC/VA/ (0000075252) (Subject)
- INSIDERSEC Form 4 filed by Accendra Health Inc.4 - ACCENDRA HEALTH INC/VA/ (0000075252) (Issuer)
- SECAmendment: Accendra Health Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits8-K/A - ACCENDRA HEALTH INC/VA/ (0000075252) (Filer)
- INSIDEREVP & CFO Leon Jonathan A covered exercise/tax liability with 4,265 shares, decreasing direct ownership by 1% to 286,268 units (SEC Form 4) (for withholding tax)4 - ACCENDRA HEALTH INC/VA/ (0000075252) (Issuer)
- SECAccendra Health Inc. filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure8-K - ACCENDRA HEALTH INC/VA/ (0000075252) (Filer)
- PRAccendra Health Names Kenneth Gardner-Smith as President and Chief Executive Officer to Lead the Company’s Next Chapter of GrowthGardner-Smith to Succeed Ed Pesicka Following Previously Announced Retirement Company Announces Scott Lloyd as Chief Commercial Officer Accendra Health, Inc. (NYSE:ACH) (the "Company") today named Kenneth Gardner-Smith as the Company’s next President and Chief Executive Officer. Gardner-Smith, who has served on the Company’s Board of Directors since March 2022, is expected to assume the role early in the fourth quarter 2026. He will succeed Edward A. Pesicka, who announced his intent to retire in August. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260917344754/en/Kenneth Gardner-Smith Gardner-Smith brings deep experience
- SECAccendra Health Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits8-K - ACCENDRA HEALTH INC/VA/ (0000075252) (Filer)
- PRAccendra Health Updates on Capital Allocation and CEO Succession Timing PlansAccendra Health (the "Company") is providing an update on its capital allocation plans and the timeline for the replacement of its chief executive officer. Given recent market conditions, the Company has determined that it is in the best interest of stakeholders not to put in place an at-the-market issuance program. The program was intended to allow the Company to opportunistically issue modest amounts of equity over time, with the proceeds to be used to reduce outstanding indebtedness, including debt trading at discounts to par value. The program was never intended as a source of liquidity for the Company. Not implementing the program will have no impact on the Company’s results of opera
- ANALYSTAccendra Health downgraded by Citigroup with a new price targetCitigroup downgraded Accendra Health from Buy to Neutral and set a new price target of $1.50
- ANALYSTAccendra Health downgraded by Robert W. Baird with a new price targetRobert W. Baird downgraded Accendra Health from Outperform to Neutral and set a new price target of $1.50
- SECSEC Form 8-A12B filed by Accendra Health Inc.8-A12B - ACCENDRA HEALTH INC/VA/ (0000075252) (Filer)
- SECAccendra Health Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Material Modification to Rights of Security Holders, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Regulation FD Disclosure, Financial Statements and Exhibits8-K - ACCENDRA HEALTH INC/VA/ (0000075252) (Filer)
- SECSEC Form 10-Q filed by Accendra Health Inc.10-Q - ACCENDRA HEALTH INC/VA/ (0000075252) (Filer)
- SECAccendra Health Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits8-K - ACCENDRA HEALTH INC/VA/ (0000075252) (Filer)
- PRAccendra Health Announces Adoption of Tax Asset Preservation Plan To Protect Long Term Shareholder ValueAccendra Health, Inc. (NYSE:ACH) (the Company) announced today that its Board of Directors adopted a Section 382 Rights Agreement (the "Tax Asset Preservation Plan") designed to protect long-term shareholder value by facilitating the Company’s ability to preserve its net operating loss carryforwards ("NOLs") and certain other tax attributes. A company generally experiences an ownership change if the percentage of the value of its stock owned by certain "5-percent shareholders," as such term is defined in Section 382 of the Code, increases by more than 50 percentage points over a rolling three-year period. The Tax Asset Preservation Plan is intended to reduce the likelihood of such an "own
- PRAccendra Health Reports Second Quarter 2026 Financial ResultsReduced Total Debt By $385 Million In Second Quarter CEO Ed Pesicka Announces Intention To Retire By The End of 2026 Accendra Health, Inc. (NYSE:ACH) (the Company) today reported financial results for the second quarter ended June 30, 2026. Unless otherwise noted, the results herein reflect the Company’s continuing operations, which represent what was previously the Patient Direct segment and certain functional operations. "Throughout the second quarter, we moved farther along toward the complete separation from Owens & Minor while also putting a large commercial payor exit behind us. In the last six months, we have eliminated well over $125 million of annualized operating expense direc
- SECAccendra Health Inc. filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits8-K - ACCENDRA HEALTH INC/VA/ (0000075252) (Filer)
- PRAccendra Health’s Ed Pesicka Announces Intent to Retire; Board of Directors Has Begun Successor SearchAccendra Health, Inc. (NYSE:ACH) (the Company) today announced that President and Chief Executive Officer Edward A. Pesicka has informed the Board of Directors of his plan to retire by the end of 2026, after more than seven years with the Company. Mr. Pesicka will also retire from the Company’s Board of Directors before the end of the year. The Board of Directors maintains a long-standing, robust succession planning process established to address officer succession. Through that process, the Board has previously identified potential candidates with the capabilities to succeed Mr. Pesicka. With Mr. Pesicka’s decision and announcement, the Board will leverage that preparation to comprehensive
- PRAccendra Health Announces Leadership Appointments in IT and ProcurementAccendra Health today announced key leadership appointments in Information Technology and Procurement, reinforcing our commitment to building a stronger operational foundation and positioning the company for long-term growth. These appointments reflect a deliberate shift to better align strategy and execution as we continue our evolution as a pure play home-based care organization dedicated to advancing healthcare in the home and beyond.Nicholas (Nick) Piecora was promoted to Senior Vice President & Chief Information Officer in May, reporting to Edward Pesicka, President & Chief Executive Officer, and Agnes Ansay has joined the company as Vice President & Chief Procurement Officer, effective
- PRAccendra Health Announces Second Quarter 2026 Earnings Release Date and Conference CallAccendra Health, Inc. (NYSE:ACH) (the "Company") plans to release financial results for the second quarter of 2026 on Monday, August 10, 2026, before trading begins on the New York Stock Exchange. The Company will host a conference call for investors and analysts at 8:00 a.m. EDT on the same day. Participants may access the call via the toll-free dial-in number at 1-888-300-2035, or the toll dial-in number at 1-646-517-7437. The conference ID access code is 1058917. All interested stakeholders are encouraged to access the simultaneous live webcast by visiting the Investor Relations page of the Accendra Health website available at investors.accendra.com/events-and-presentations/. A repla
- SECSEC Form EFFECT filed by Accendra Health Inc.EFFECT - ACCENDRA HEALTH INC/VA/ (0000075252) (Filer)
- SECSEC Form S-3 filed by Accendra Health Inc.S-3 - ACCENDRA HEALTH INC/VA/ (0000075252) (Filer)
- SECAccendra Health Inc. filed SEC Form 8-K: Other Events8-K - ACCENDRA HEALTH INC/VA/ (0000075252) (Filer)
ACH FAQ
6 questionsWhat does Accendra Health Inc. do?
Aluminum Corporation of China Limited, together with its subsidiaries, manufactures and sells alumina, primary aluminum, and energy products in the People's Republic of China. The company operates through Alumina, Primary Aluminum, Trading, and Energy segments. The Alumina segment mines for and purchases bauxite and other raw materials; and produces and sells alumina, as well as refined alumina. The Primary Aluminum segment procures alumina and other raw materials, supplemental materials, and electrical power; and produces and sells aluminum and aluminum-related products, such as carbon...Where does ACH stock trade?
Accendra Health Inc. (ACH) is listed on NYSE.What sector and industry is ACH in?
Accendra Health Inc. operates in the Health Care sector, Medical Specialities industry.What are analysts saying about ACH?
Accendra Health Inc. has had 4 recent analyst actions on file. The most recent action was from Robert W. Baird: Neutral with a $150.00 price target on 2026-08-11. Recent price targets cluster around $150.00.What companies are similar to ACH?
Notable peers in the same industry include UNH (UnitedHealth Group Incorporated), ANTM (Anthem Inc.), ELV (Elevance Health Inc.), CI (The Cigna Group), NTRA (Natera Inc.). Compare ACH side-by-side with any of them on Quantisnow.How can I track ACH on Quantisnow?
Quantisnow aggregates Accendra Health Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow ACH to receive live email and push alerts on every new disclosure.